404594-16-7 Usage
General Description
1-BOC-3-(methylaminomethyl)-pyrrolidine is a chemical compound that belongs to the class of pyrrolidine derivatives. It is commonly used in organic synthesis as a building block for pharmaceuticals and agrochemicals. The "1-BOC" in its name refers to the tert-butoxycarbonyl (BOC) protecting group attached to the nitrogen atom, which helps to prevent unwanted reactions during chemical synthesis. The "methylaminomethyl" group indicates the presence of a nitrogen-containing functional group, which can participate in various chemical reactions. Pyrrolidine is a five-membered heterocyclic ring system that is often found in natural products and pharmaceutical compounds due to its biological activity. The combination of these functional groups makes 1-BOC-3-(methylaminomethyl)-pyrrolidine a valuable tool for the preparation of diverse organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 404594-16-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,4,5,9 and 4 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 404594-16:
(8*4)+(7*0)+(6*4)+(5*5)+(4*9)+(3*4)+(2*1)+(1*6)=137
137 % 10 = 7
So 404594-16-7 is a valid CAS Registry Number.
404594-16-7Relevant articles and documents
OXOPYRIDO[1,2-A]PYRIMIDINE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION
-
Page/Page column 35; 36, (2020/07/14)
The present invention relates to novel compounds of formula (I), wherein R1 to R7 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
Novel Compounds
-
Page/Page column 61, (2017/07/06)
The present invention relates to novel compounds and methods for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention relates to the inhibition of ubiquitin C- terminal hydrolase 30 or Ubiquitin Specific Peptidase 30 (USP30). The invention further relates to the use of DUB inhibitors in the treatment of conditions involving mitochondrial dysfunction and cancer. Compounds of the invention include compounds having the formula (I): (I) or a pharmaceutically acceptable salt thereof, wherein R1a, R1b, R1c, R1d, R1e, R1f, R1g, R2, X, L and A are as defined herein.
